Rabbit Anti-CTNNB1 Recombinant Antibody (CBYY-C2286) (CBMAB-C3724-YY)

Basic Information
Application | Note |
IF(ICC) | 1:20-1:100 |
ELISA | 1:5,000-1:10,000 |
IHC-P | 1:100-1:500 |
FC | 1:25-1:100 |
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Beta-catenin destruction complex disassembly
Beta-catenin-TCF complex assembly
Branching involved in blood vessel morphogenesis
Canonical Wnt signaling pathway
Canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation
Canonical Wnt signaling pathway involved in negative regulation of apoptotic process
Canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation
Canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition
Cell adhesion
Cell-cell adhesion
Cellular response to growth factor stimulus
Cellular response to indole-3-methanol
Detection of muscle stretch
Embryonic skeletal limb joint morphogenesis
Endothelial tube morphogenesis
Entry of bacterium into host cell
Epithelial to mesenchymal transition
Hair cell differentiation
Midbrain dopaminergic neuron differentiation
Negative regulation of angiogenesis
Negative regulation of apoptotic process
Negative regulation of cell population proliferation
Negative regulation of mitotic cell cycle, embryonic
Negative regulation of protein sumoylation
Negative regulation of transcription, DNA-templated
Neuron projection extension
Positive regulation of apoptotic process
Positive regulation of DNA-binding transcription factor activity
Positive regulation of epithelial to mesenchymal transition
Positive regulation of heparan sulfate proteoglycan biosynthetic process
Positive regulation of histone H3-K4 methylation
Positive regulation of muscle cell differentiation
Positive regulation of neuroblast proliferation
Positive regulation of neuron apoptotic process
Positive regulation of telomerase activity
Positive regulation of telomere maintenance via telomerase
Positive regulation of transcription, DNA-templated
Positive regulation of transcription by RNA polymerase II
Positive regulation of type I interferon production
Proteasome-mediated ubiquitin-dependent protein catabolic process
Protein localization to cell surface
Protein polyubiquitination
Regulation of angiogenesis
Regulation of calcium ion import
Regulation of canonical Wnt signaling pathway
Regulation of centriole-centriole cohesion
Regulation of centromeric sister chromatid cohesion
Regulation of fibroblast proliferation
Regulation of nephron tubule epithelial cell differentiation
Regulation of neurogenesis
Regulation of protein localization to cell surface
Regulation of smooth muscle cell proliferation
Regulation of transcription initiation from RNA polymerase II promoter
Response to drug
Response to estradiol
Stem cell population maintenance
Sympathetic ganglion development
Viral process
Wnt signaling pathway
Wnt signaling pathway, calcium modulating pathway
Pilomatrixoma (PTR): Common benign skin tumor.
Ovarian cancer (OC): The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.
Mesothelioma, malignant (MESOM): An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos.
Neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV): An autosomal dominant disorder characterized by global developmental delay, severe intellectual disability with absent or very limited speech, microcephaly, spasticity, and visual abnormalities.
Vitreoretinopathy, exudative 7 (EVR7): A form of exudative vitreoretinopathy, a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.
Ubiquitinated by the SCF(BTRC) E3 ligase complex when phosphorylated by GSK3B, leading to its degradation. Ubiquitinated by a E3 ubiquitin ligase complex containing UBE2D1, SIAH1, CACYBP/SIP, SKP1, APC and TBL1X, leading to its subsequent proteasomal degradation.Ubiquitinated and degraded following interaction with SOX9 (By similarity).
S-nitrosylation at Cys-619 within adherens junctions promotes VEGF-induced, NO-dependent endothelial cell permeability by disrupting interaction with E-cadherin, thus mediating disassembly adherens junctions.
O-glycosylation at Ser-23 decreases nuclear localization and transcriptional activity, and increases localization to the plasma membrane and interaction with E-cadherin CDH1.
Deacetylated at Lys-49 by SIRT1.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Mouse Anti-CTNNB1 Recombinant Antibody (CBT3902) (CAT#: V2LY-0625-LY727)
Mouse Anti-CTNNB1 Recombinant Antibody (CBFYC-2402) (CAT#: V2LY-0125-LY313)
Mouse Anti-CTNNB1 Recombinant Antibody (EC96) (CAT#: V2LY-0624-LY96)
Mouse Anti-CTNNB1 Recombinant Antibody (CBFYC-2411) (CAT#: CBMAB-C2484-FY)
Mouse Anti-CTNNB1 Recombinant Antibody (CBFYC-2403) (CAT#: V2LY-0125-LY314)
Mouse Anti-CTNNB1 Recombinant Antibody (CBFYC-2410) (CAT#: V2LY-0125-LY320)
Rabbit Anti-CTNNB1 Recombinant Antibody (CBWJC-2083) (CAT#: V2LY-0125-LY325)
Mouse Anti-CTNNB1 Recombinant Antibody (CBFYC-2404) (CAT#: V2LY-0125-LY315)
Mouse Anti-CTNNB1 Recombinant Antibody (CBT3586) (CAT#: V2LY-0625-LY2367)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
